Published in Eur Respir J on June 30, 2011
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. Lancet (2014) 3.21
Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis (2011) 2.59
Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev (2014) 2.43
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med (2013) 1.91
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial. Lancet Respir Med (2015) 1.74
Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis. PLoS One (2012) 1.48
HIV-1 and the immune response to TB. Future Virol (2013) 0.97
Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis. PLoS One (2011) 0.93
Incremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting: a multivariable analysis. Thorax (2013) 0.89
Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study. BMC Infect Dis (2012) 0.84
Accuracy of the interferon-γ release assay for the diagnosis of active tuberculosis among HIV-seropositive individuals: a systematic review and meta-analysis. BMC Infect Dis (2016) 0.75
The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology (1982) 79.76
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29
A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol (1996) 20.25
Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology (2010) 14.07
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature (2010) 10.37
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep (2010) 8.16
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol (2009) 8.13
Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS (2005) 6.83
6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet (2011) 5.57
Tuberculosis. Lancet (2007) 5.45
Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem (2007) 5.23
Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev (2010) 4.95
Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med (2011) 4.29
An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med (2010) 4.24
Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis (2010) 3.96
Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med (2008) 2.85
Screening for tuberculosis in adults with advanced HIV infection prior to preventive therapy. Int J Tuberc Lung Dis (2004) 2.81
Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis (2010) 2.72
Eliminating latent tuberculosis. Trends Microbiol (2009) 2.47
Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet (2003) 2.41
Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med (2006) 2.40
Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg Infect Dis (2006) 2.29
Limitations of sensitivity, specificity, likelihood ratio, and bayes' theorem in assessing diagnostic probabilities: a clinical example. Epidemiology (1997) 2.28
Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst (2003) 2.11
Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ (2010) 2.03
Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr (2011) 1.95
Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. Int J Tuberc Lung Dis (2006) 1.89
When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk. Arch Intern Med (2005) 1.78
Test research versus diagnostic research. Clin Chem (2004) 1.72
Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med (2009) 1.57
Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control. Int J Tuberc Lung Dis (2009) 1.46
Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child (2009) 1.29
Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting? Eur Respir J (2011) 1.25
Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics (2009) 1.23
Diagnostic studies as multivariable, prediction research. J Epidemiol Community Health (2002) 1.21
Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects. Am J Respir Crit Care Med (2009) 1.09
Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis. Am J Respir Crit Care Med (2009) 1.09
Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect Dis (2010) 1.07
Redundancy of single diagnostic test evaluation. Epidemiology (1999) 1.05
Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay. AIDS (2009) 0.93
Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients. East Afr Med J (2008) 0.86
Undiagnosed active tuberculosis in HIV-infected patients commencing antiretroviral therapy. Clin Infect Dis (2010) 0.83
False-negative results by enzyme-linked immunospot assay for interferon-gamma among patients with culture-confirmed tuberculosis. J Infect (2009) 0.83
Risk factors for tuberculosis among HIV-infected patients receiving antiretroviral treatment. Am J Respir Crit Care Med (2005) 0.78
Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr (1999) 6.43
False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis (2006) 5.08
Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med (2001) 5.06
Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry (2000) 4.44
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet (2001) 4.33
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J (2008) 4.32
Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis (2007) 4.04
One hundred questions of importance to the conservation of global biological diversity. Conserv Biol (2009) 3.95
Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ (2001) 3.81
Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol (2001) 3.79
Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 3.59
Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis (2000) 3.58
Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis (2007) 3.25
Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet (2001) 3.15
Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. Int J Epidemiol (2005) 2.97
Screening for tuberculosis in adults with advanced HIV infection prior to preventive therapy. Int J Tuberc Lung Dis (2004) 2.81
Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting. Int J Tuberc Lung Dis (2010) 2.59
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study. J Thromb Haemost (2006) 2.57
Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int J Tuberc Lung Dis (2001) 2.51
Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults. Int J Tuberc Lung Dis (2006) 2.49
Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13). Hum Mol Genet (2001) 2.48
Depression as a risk factor for ischaemic heart disease in men: population based case-control study. BMJ (1998) 2.38
Do the attitudes and beliefs of young teenagers towards general practice influence actual consultation behaviour? Br J Gen Pract (2000) 2.29
Recognizing emergency medicine in India. Natl Med J India (2001) 2.27
Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. Int J Tuberc Lung Dis (2011) 2.15
Reliability and accuracy of the Glasgow Coma Scale with experienced and inexperienced users. Lancet (1991) 2.13
A model to rule out smear-negative tuberculosis among symptomatic HIV patients using C-reactive protein. Int J Tuberc Lung Dis (2012) 2.13
The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis (2008) 2.09
Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J (2011) 2.07
Preventing injuries in children: cluster randomised controlled trial in primary care. BMJ (1999) 2.01
The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review. Int J Tuberc Lung Dis (2013) 1.96
Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. Int J Tuberc Lung Dis (2010) 1.92
Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi. Trans R Soc Trop Med Hyg (1998) 1.89
Plasticity in chromosome number and testing of essential genes in Leishmania by targeting. Proc Natl Acad Sci U S A (1993) 1.88
Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect (2005) 1.87
Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr (2000) 1.86
Radiography of the lumbar spine in primary care patients with low back pain: randomised controlled trial. BMJ (2001) 1.85
Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). Clin Infect Dis (1996) 1.75
Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe. Int J Tuberc Lung Dis (2011) 1.74
Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect (2011) 1.73
Evaluation of the World Health Organization algorithm for the diagnosis of HIV-associated sputum smear-negative tuberculosis. Int J Tuberc Lung Dis (2011) 1.71
A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva. J Exp Med (1991) 1.70
Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis (2005) 1.69
Tuberculosis and gender: exploring the patterns in a case control study in Malawi. Int J Tuberc Lung Dis (2004) 1.67
Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect (1997) 1.64
Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations. AIDS (2001) 1.64
Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost (2009) 1.63
Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J Infect Dis (1998) 1.62
CD4 and total lymphocyte counts as predictors of HIV disease progression. QJM (1996) 1.58
Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J (2010) 1.57
Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection. Int J Tuberc Lung Dis (2011) 1.57
HIV epidemic trend and antiretroviral treatment need in Karonga District, Malawi. Epidemiol Infect (2007) 1.57
Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol (2005) 1.57
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J (2010) 1.57
Educational level is associated with condom use within non-spousal partnerships in four cities of sub-Saharan Africa. AIDS (2001) 1.56
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer. Br J Cancer (2001) 1.56
A new locus for autosomal dominant retinitis pigmentosa on the short arm of chromosome 17. Hum Mol Genet (1994) 1.56
A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem (2000) 1.54
Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series. J Thromb Haemost (2011) 1.54
Nucleic acid amplification tests for the diagnosis of tuberculous lymphadenitis: a systematic review. Int J Tuberc Lung Dis (2007) 1.52
CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol (2001) 1.51
Use of simulated sputum specimens to estimate the specificity of laboratory-diagnosed tuberculosis. Int J Tuberc Lung Dis (2010) 1.50
Condom use and its association with HIV/sexually transmitted diseases in four urban communities of sub-Saharan Africa. AIDS (2001) 1.49
Predicting outcomes and drug resistance with standardised treatment of active tuberculosis. Eur Respir J (2010) 1.49
The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentrates. Transfusion (1995) 1.49
Novel tests for diagnosing tuberculous pleural effusion: what works and what does not? Eur Respir J (2008) 1.48
Comparison of two versus three smears in identifying culture-positive tuberculosis patients in a rural African setting with high HIV prevalence. Int J Tuberc Lung Dis (2001) 1.48
Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis. Scand J Immunol (1998) 1.47
A comparative study of the polymerase chain reaction and conventional procedures for the diagnosis of tuberculous pleural effusion. Tuber Lung Dis (1992) 1.45
What has Karonga taught us? Tuberculosis studied over three decades. Int J Tuberc Lung Dis (2009) 1.45
Concurrent infections and HIV pathogenesis. AIDS (2000) 1.44
Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J Natl Cancer Inst (1999) 1.44
Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J Infect Dis (1998) 1.43
Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole. BMC Infect Dis (2006) 1.43
Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998. Int J Tuberc Lung Dis (2000) 1.42
Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia. Intensive Care Med (1995) 1.41
Should tuberculin skin testing be a prerequisite to prolonged IPT for HIV-infected adults? Int J Tuberc Lung Dis (2012) 1.41
Pituitary dysfunction in recently post-menopausal women. Nottingham EPIC Study Group. Clin Endocrinol (Oxf) (1997) 1.39
Investigation and management of iron deficiency anaemia in general practice: a cluster randomised controlled trial of a simple management prompt. Postgrad Med J (2002) 1.36
Does bleach processing increase the accuracy of sputum smear microscopy for diagnosing pulmonary tuberculosis? J Clin Microbiol (2010) 1.35
Microcolony culture techniques for tuberculosis diagnosis: a systematic review. Int J Tuberc Lung Dis (2011) 1.35
High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease. Eur J Immunol (2000) 1.32
Tuberculosis diagnosed during pregnancy: a prospective study from London. Thorax (2000) 1.32
Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J (2009) 1.30
Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Int J Tuberc Lung Dis (2009) 1.30
Mobile health to improve tuberculosis care and control: a call worth making. Int J Tuberc Lung Dis (2013) 1.27
Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting? Eur Respir J (2011) 1.25
Induced abortion among women attending antenatal clinics in Yaounde, Cameroon. East Afr Med J (2004) 1.24
Diagnosing HIV-associated tuberculosis: reducing costs and diagnostic delay. Int J Tuberc Lung Dis (2000) 1.23
Survival after cardiopulmonary resuscitation in an urban Indian hospital. Natl Med J India (1999) 1.23
Global tuberculosis trends: a reflection of changes in tuberculosis control or in population health? Int J Tuberc Lung Dis (2009) 1.23
Field-based random sampling without a sampling frame: control selection for a case-control study in rural Africa. Trans R Soc Trop Med Hyg (2001) 1.22
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models. Br J Pharmacol (2007) 1.20
An increase in expression of a Mycobacterium tuberculosis mycolyl transferase gene (fbpB) occurs early after infection of human monocytes. Mol Microbiol (2001) 1.19